Half-year report · HY
3417.TEDINET S100X15G
Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥182.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥349.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥175.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥1.2bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥821m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.9bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.8bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.2bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥988m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.2bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥972m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥144.9bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥139.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥136.7bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥112.6bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥108.3bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥32.4bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥31.1bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥29.9bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.2bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥9.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥7.9bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥362m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥915m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.5bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.9bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Net assets per share | ¥86.57 | at 2025-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥193.49 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥72.44 | at 2024-09-30 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 22.3% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.2% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.8% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 463
| Item | Context | Value | Unit |
|---|---|---|---|
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所スタンダード市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は100株です。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)ロート製薬株式会社 | |
| Address major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)大阪府大阪市生野区巽西１丁目８－１ | |
| Name major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)東邦ホールディングス株式会社 | |
| Address major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)東京都世田谷区代沢４丁目43－11 | |
| Name major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)国分グループ本社株式会社 | |
| Address major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)東京都中央区日本橋１丁目１－１ | |
| Name major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)大木ヘルスケアホールディングス取引先持株会 | |
| Address major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)東京都文京区音羽２丁目１－４ | |
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)株式会社三菱UFJ銀行 | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１丁目４－５ | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)株式会社ツムラ | |
| Address major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)東京都港区赤坂２丁目17－11 | |
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)久光製薬株式会社 | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)佐賀県鳥栖市田代大官町408 | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)株式会社明治 | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)東京都中央区京橋２丁目２－１ | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)ＤＢＳ ＢＡＮＫ ＬＴＤ ７００１７０（常任代理人 株式会社みずほ銀行決済営業部） | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Text · Plus | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)大鵬薬品工業株式会社 | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都千代田区神田錦町１－27 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)大木ヘルスケアホールディングス株式会社 | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都文京区音羽２丁目１－４ | |
| Name of shareholder treasury shares etc | InterimInstant_Row2Member | Original text (Japanese)大木化粧品株式会社 | |
| Address of shareholder treasury shares etc | InterimInstant_Row2Member | Original text (Japanese)大分県大分市大道町５丁目１－10 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Note on change of independent auditors financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |